Free Trial

Ultralife (ULBI) Competitors

Ultralife logo
$6.44 -0.10 (-1.50%)
As of 12:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ULBI vs. ABAT, ELVA, EAF, MVST, and CHPT

Should you buy Ultralife stock or one of its competitors? Ultralife's main competitors and comparable companies include American Battery Technology (ABAT), Electrovaya (ELVA), GrafTech International (EAF), Microvast (MVST), and ChargePoint (CHPT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "electrical components & equipment" industry.

How does Ultralife compare to American Battery Technology?

Ultralife (NASDAQ:ULBI) and American Battery Technology (NASDAQ:ABAT) are both small-cap industrials companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

30.7% of Ultralife shares are held by institutional investors. Comparatively, 9.9% of American Battery Technology shares are held by institutional investors. 42.9% of Ultralife shares are held by insiders. Comparatively, 7.8% of American Battery Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, American Battery Technology had 10 more articles in the media than Ultralife. MarketBeat recorded 10 mentions for American Battery Technology and 0 mentions for Ultralife. American Battery Technology's average media sentiment score of 0.48 beat Ultralife's score of 0.00 indicating that American Battery Technology is being referred to more favorably in the news media.

Company Overall Sentiment
Ultralife Neutral
American Battery Technology Neutral

Ultralife has a net margin of -3.50% compared to American Battery Technology's net margin of -337.50%. Ultralife's return on equity of 2.75% beat American Battery Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-3.50% 2.75% 1.66%
American Battery Technology -337.50%-64.63%-61.52%

Ultralife has higher revenue and earnings than American Battery Technology. Ultralife is trading at a lower price-to-earnings ratio than American Battery Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$187.24M0.58-$5.90M-$0.40N/A
American Battery Technology$21.74M14.10-$73.38M-$0.57N/A

Ultralife has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, American Battery Technology has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market.

American Battery Technology has a consensus target price of $6.00, suggesting a potential upside of 179.07%. Given American Battery Technology's stronger consensus rating and higher possible upside, analysts plainly believe American Battery Technology is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
American Battery Technology
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Ultralife beats American Battery Technology on 9 of the 17 factors compared between the two stocks.

How does Ultralife compare to Electrovaya?

Electrovaya (NASDAQ:ELVA) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Electrovaya currently has a consensus price target of $17.50, suggesting a potential upside of 169.23%. Given Electrovaya's stronger consensus rating and higher possible upside, research analysts plainly believe Electrovaya is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electrovaya
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.83
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Electrovaya has a beta of 1.64, meaning that its stock price is 64% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

In the previous week, Electrovaya had 4 more articles in the media than Ultralife. MarketBeat recorded 4 mentions for Electrovaya and 0 mentions for Ultralife. Electrovaya's average media sentiment score of 0.42 beat Ultralife's score of 0.00 indicating that Electrovaya is being referred to more favorably in the media.

Company Overall Sentiment
Electrovaya Neutral
Ultralife Neutral

Electrovaya has a net margin of 6.14% compared to Ultralife's net margin of -3.50%. Electrovaya's return on equity of 7.96% beat Ultralife's return on equity.

Company Net Margins Return on Equity Return on Assets
Electrovaya6.14% 7.96% 4.54%
Ultralife -3.50%2.75%1.66%

22.5% of Electrovaya shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 42.9% of Ultralife shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Electrovaya has higher earnings, but lower revenue than Ultralife. Ultralife is trading at a lower price-to-earnings ratio than Electrovaya, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Electrovaya$63.83M5.09$3.36M$0.1159.09
Ultralife$187.24M0.58-$5.90M-$0.40N/A

Summary

Electrovaya beats Ultralife on 14 of the 17 factors compared between the two stocks.

How does Ultralife compare to GrafTech International?

GrafTech International (NYSE:EAF) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Ultralife has lower revenue, but higher earnings than GrafTech International. Ultralife is trading at a lower price-to-earnings ratio than GrafTech International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GrafTech International$504.13M0.49-$219.84M-$6.80N/A
Ultralife$187.24M0.58-$5.90M-$0.40N/A

GrafTech International has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

GrafTech International presently has a consensus target price of $10.67, indicating a potential upside of 13.21%. Given GrafTech International's stronger consensus rating and higher probable upside, analysts plainly believe GrafTech International is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GrafTech International
2 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, GrafTech International had 1 more articles in the media than Ultralife. MarketBeat recorded 1 mentions for GrafTech International and 0 mentions for Ultralife. GrafTech International's average media sentiment score of 0.10 beat Ultralife's score of 0.00 indicating that GrafTech International is being referred to more favorably in the media.

Company Overall Sentiment
GrafTech International Neutral
Ultralife Neutral

92.8% of GrafTech International shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 1.2% of GrafTech International shares are owned by company insiders. Comparatively, 42.9% of Ultralife shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Ultralife has a net margin of -3.50% compared to GrafTech International's net margin of -34.58%. Ultralife's return on equity of 2.75% beat GrafTech International's return on equity.

Company Net Margins Return on Equity Return on Assets
GrafTech International-34.58% N/A -17.50%
Ultralife -3.50%2.75%1.66%

Summary

GrafTech International beats Ultralife on 8 of the 15 factors compared between the two stocks.

How does Ultralife compare to Microvast?

Ultralife (NASDAQ:ULBI) and Microvast (NASDAQ:MVST) are both small-cap industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Microvast has a consensus price target of $4.00, indicating a potential upside of 554.13%. Given Microvast's stronger consensus rating and higher possible upside, analysts clearly believe Microvast is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Microvast
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Ultralife has higher earnings, but lower revenue than Microvast. Microvast is trading at a lower price-to-earnings ratio than Ultralife, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$187.24M0.58-$5.90M-$0.40N/A
Microvast$367.56M0.64-$29.22M-$0.02N/A

In the previous week, Microvast had 1 more articles in the media than Ultralife. MarketBeat recorded 1 mentions for Microvast and 0 mentions for Ultralife. Ultralife's average media sentiment score of 0.00 equaled Microvast'saverage media sentiment score.

Company Overall Sentiment
Ultralife Neutral
Microvast Neutral

30.7% of Ultralife shares are held by institutional investors. Comparatively, 20.7% of Microvast shares are held by institutional investors. 42.9% of Ultralife shares are held by company insiders. Comparatively, 44.8% of Microvast shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Microvast has a net margin of 13.95% compared to Ultralife's net margin of -3.50%. Ultralife's return on equity of 2.75% beat Microvast's return on equity.

Company Net Margins Return on Equity Return on Assets
Ultralife-3.50% 2.75% 1.66%
Microvast 13.95%-10.34%-4.64%

Ultralife has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Microvast has a beta of 3.6, meaning that its stock price is 260% more volatile than the broader market.

Summary

Microvast beats Ultralife on 10 of the 15 factors compared between the two stocks.

How does Ultralife compare to ChargePoint?

ChargePoint (NYSE:CHPT) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Ultralife has a net margin of -3.50% compared to ChargePoint's net margin of -40.59%. Ultralife's return on equity of 2.75% beat ChargePoint's return on equity.

Company Net Margins Return on Equity Return on Assets
ChargePoint-40.59% -3,366.29% -15.95%
Ultralife -3.50%2.75%1.66%

37.8% of ChargePoint shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 4.2% of ChargePoint shares are held by insiders. Comparatively, 42.9% of Ultralife shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

ChargePoint has a beta of 1.7, meaning that its stock price is 70% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

Ultralife has lower revenue, but higher earnings than ChargePoint. Ultralife is trading at a lower price-to-earnings ratio than ChargePoint, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ChargePoint$411.22M0.57-$220.20M-$7.18N/A
Ultralife$187.24M0.58-$5.90M-$0.40N/A

In the previous week, ChargePoint had 5 more articles in the media than Ultralife. MarketBeat recorded 5 mentions for ChargePoint and 0 mentions for Ultralife. ChargePoint's average media sentiment score of 0.93 beat Ultralife's score of 0.00 indicating that ChargePoint is being referred to more favorably in the media.

Company Overall Sentiment
ChargePoint Positive
Ultralife Neutral

ChargePoint currently has a consensus target price of $7.07, indicating a potential downside of 18.54%. Given ChargePoint's stronger consensus rating and higher possible upside, research analysts plainly believe ChargePoint is more favorable than Ultralife.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ChargePoint
3 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.70
Ultralife
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

ChargePoint beats Ultralife on 8 of the 15 factors compared between the two stocks.

Get Ultralife News Delivered to You Automatically

Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ULBI vs. The Competition

MetricUltralifeElectrical Equipment IndustryIndustrials SectorNASDAQ Exchange
Market Cap$107.39M$10.66B$10.08B$13.35B
Dividend YieldN/A2.34%96.74%17.39%
P/E Ratio-16.1148.4426.4326.17
Price / Sales0.571,549.58270.15107.74
Price / Cash10.6934.7624.0953.24
Price / Book0.826.904.766.30
Net Income-$5.90M$140.61M$614.99M$381.95M
7 Day Performance-0.28%-2.19%-1.01%-0.80%
1 Month Performance5.09%-5.66%-3.94%-5.26%
1 Year Performance-3.71%-4.93%1.68%0.89%

Ultralife Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ULBI
Ultralife
1.2309 of 5 stars
$6.44
-1.5%
N/A-7.6%$107.39M$187.24MN/A678
ABAT
American Battery Technology
2.044 of 5 stars
$2.19
-3.5%
$6.00
+174.0%
-59.9%$323.65M$21.74MN/A163
ELVA
Electrovaya
3.9928 of 5 stars
$6.35
+3.6%
$17.50
+175.6%
-3.6%$303.48M$71.57M57.73123
EAF
GrafTech International
1.7476 of 5 stars
$8.57
-14.0%
$10.67
+24.5%
-38.3%$259.88M$512.92MN/A1,071
MVST
Microvast
2.3478 of 5 stars
$0.65
+0.2%
$4.00
+517.6%
-86.8%$248.45M$427.52MN/A1,908

Related Companies and Tools


This page (NASDAQ:ULBI) was last updated on 10/7/2026 by MarketBeat.com Staff.
From Our Partners